Cell cycle, cancer, and cell death Flashcards

1
Q

G0 phase

A

quiescent, intact proliferation capacity, non-cycling

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

G1 phase (gap 1)

A

duration between completion of cell division and initiation of DNA replication, where cells start building cell mass

  • growth and preparation
  • RNA and protein synthesis also take place here. Organelles are duplicated
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

S-phase (synthesis)

A

DNA replication
multiple replication forks are activated on each chromosome
- then chromosomes are condensed into heterochromatin
- time during this phase is fairly constant across cell types

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

G2-phase (gap 2)

A

duration between completion of DNA replication and initiation of cell division

  • preparation for nuclear division in mitosis
  • there is a checkpoint that assess nuclear integrity, ensures that DNA is intact
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

M-phase

A

mitosis

- prophase, metaphase, anaphase, telophase

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Cdc25

A

dephosphorylates the cyclin-CDK complex at its inhibitory site, activating the cyclin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

CDK1

A

partners with cyclins A and B
triggers G2 –> M transition. Cyclin A is synthesized in S and destroyed starting at prometaphase
Cyclins B are synthesized in S/G2 and destroyed following the completion of chromosome attachment to the spindle
CKI (inhibitors p57, p27, p21) kip family

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

CDK2

A

cyclins A, E
Triggers G1 –> S transition
- stabilizes the replication complexes during DNA replication at the replication forks
CKI (inhibitors p57, p27, p21) Kip family

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

CDK4, CDK6

A

cyclin partner D
phosphorylation of the retinoblastoma susceptibility protein in G1. Triggers passage of the restriction point and cyclin E synthesis in some cell types. Extracellular growth factors control synthesis of D cyclins
CKI (inhibitor) - P16, p15, p18, p19 (INK family)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

p16 CKI

A

Inhibits Cdk4 and Cdk6
Cooperates with retinoblastoma susceptibility protein in growth regulation. Altered in a high percentage of human cancers. This gene overlaps teh gene for p19, an important regulator of the p53 tumor suppressor protein.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

p21 CKI

A

inhibits most CDK-cyclin complexes
- induced by p53 tumor suppressor. Cell-cycle arrest after DNA damage. Binds PCNA and inhibits DNA synthesis. Promotes cell cycle arrest in senescence and terminal differentiation. At low levels, may help assemble active Cdk-cyclin complexes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

p27 CKI

A

inhibits most CDK-cyclin complexes

- cell cycle arrest in response to growth suppressors like TGF-B and in contact inhibition and differentiation.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

cell cycle entry and progression

A

extracellular signals regulate cell cycle proteins and control growth
- Ras superfamily receive signals from catalytic receptors that have been activated by their ligand, overall effects of Ras signaling involve induction of proliferation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

R point

A

restriction point, where cells commit to going through the cell cycle, regulated by retinoblastoma protein Rb
- unphosphorylated Rb inhibits E2F. Cyclin phosphorylate Rb, then CDK2/E hy[erphosphorylate Rb and it liberates E2F transcription factor

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

G2/M transtition

A
  • activation of CDK1/cyclin B at the G2/M boundary, maintained by Cdc25
  • CDk1/cyclin B translocate to the nucleus to initiate spindle assembly
  • activated anaphase-promoting complex (APC) destroy CDk1 freeing cyclin B for degradation
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

G1 checkpoint

A

slow pathway:
- P21 binds and inhibits the CDk4/6/D.
- P21 is activated by P53 txn factor
- p21 and p53 are tumor suppressors
Faster pathway:
- activation of checkpoint kinase 2 and the inactivation of cdc25
- phosphates inactivating the cyclinD/CDK4/6 can no longer be removed and results in G1 arrest

17
Q

G2 checkpoints

A

ATM pathway - ATM senses DNA damage and signals downstream

18
Q

tumors

A

space occupying lesions that may or may not be neoplasms

19
Q

neoplasm

A

relatively autonomous abnormal growth with abnormal gene regulation
2 types: benign and malignant (–> cancer)

20
Q

cancer

A

malignant neoplasm (can produce metastasis)

21
Q

Metastasis

A

secondary growth of cancer at different location from the primary neoplasm

22
Q

Initiation

A

first step of carcinogenesis
- simple mutatino in one or more genes that control key regulatory pathways of the cell
Ex. genotoxic event (change in DNA sequence)
- irreversible, no threshold
- genotoxic agents such as chemicals, radiation, ROS, and viruses
- can be result of oncogenes or inactivation of tumor suppressor genes

23
Q

promotion

A

second step of carcinogenesis

  • selective functional enhancement of signal transduction pathways that were induced by initiator by continuous exposure
    ex) . epigenetic event (involving changes in gene regulation)
  • occurs over a long period of time, can be reversible in its early stages
  • gene activation or repression –> clonal expansion
  • threshold for time and dosing
    ex. ) inhibition of cell death
24
Q

progression

A

third step of carcinogenesis

  • continuing change of the basically unstable karyotype
    ex) . clastogenic events and other (further changes in karyotypes)
  • further complex genetic changes (translocations, deletions, gene amplifications), irreversible changes in gene expression
  • karyotype instability
  • selection for optimal growth in response to cellular environment
  • conversion of benign tumors into malignant neoplasms
25
Q

Hallmarks of cancer

A
  • acquire self-sufficiency of growth signals
  • become insensitive to growth inhibitory signals
  • evade cell death
  • acquire limitless replicative potential
  • sustain angiogenesis
  • acquire capabilities to invade tissues and metastasize
  • create genome instability
  • promote inflammation
  • avoid immune destruction
  • reprogram energy metabolism
26
Q

Oncogenes

A

expression of these genes stimulate cell division and/or growth. Tightly controlled under normal circumstances. Loss of regulation of gene expression can lead to enhanced expression –> unregulated cell division and growth
- said to be “dominant”, result from gain of function mutation

27
Q

Tumor suppressor genes

A

genes that serve to check or inhibit cell division. Loss of expression of these proteins leads to cell growth or cell division

  • in carciogenesis: inactivating mutations, deletions, loss of expression
  • germline inheritance frequently involved in cancer development
28
Q

Viral oncogenes

A

Adenovirus, hepatitis B virus, Epstein-Barr virus, hepatitis C virus

29
Q

Human oncogene examples

A

Myc, Ras, cell cyclins, ATM, PDGF, EGF/EGFR, and DNA repair proteins

30
Q

Human tumor suppressor genes

A

p53, Rb, p14ARF, p16

- p16 inhibits cyclin CDK4/6, which in turn blocks their ability to phosphorylate Rb, halts cell cycle here

31
Q

Breast Cancer

A

heterogeneous disease with features including

  • activation of human epidermal growth factor receptor 2 (HER2, encoded by ERBB2)
  • activation of hormone receptors (estrogen receptor and progesterone receptor)
  • BRCA mutations
32
Q

Estrogen receptor signaling pathway

A

breast cancer cells have relatively high ERa expression and low ERB expression.

  • the hormone receptors form dimers upon ligand binding and translocation into the cell nucleus for txn regluation
  • ER dimers bind to ERE region of target genes and recruit co-regulators
  • also act as co-regulators for other transcription
33
Q

HER2 signaling pathway

A
  • receptor tyrosine kinase located on the cell membrane and respond to a variety of ligands
  • phosphorylation of tyrosine kinase domain in the cytoplasm initiates downstream oncogenic signal pathways such as PI3K/AKT and Ras/MAPK pathways
34
Q

Mechanisms of cell death

A
  1. apoptosis: programmed cell death (suicide)
  2. autophagy (self destruction, digestion)
  3. necrosis (explosive disaster)
    Depending on morphological criteria
    - mitotic catastrophe
    - senescence (irreversible growth arrest - reproductive cell death)
35
Q

Necrosis

A
  • uncontrolled form of cell death
  • all cyell types involved, inflammation is present
  • extensive failure of normal physiological pathways essential for maintaining cellular homeostasis: regulation of ion transport, energy production (ATP depletion) and pH balance
  • cell membrane swelling and rupture, increased vacuolation, organelle degeneration, and mitochondrial swelling
  • two key players involved (Rip1 and Parp1)
36
Q

Necrosis mechanisms

A
Ca2+ overload
- mitochondrial uncoupling
- increased O2 consumption
- excessive ROS production
- ATP depletion
no caspases involved
37
Q

Apoptosis

A

triggered by DNA damage (ATM, P52)

  • death receptor signaling (CD95, Fas receptor, TNF receptor superfamily, and caspase8 mediated)
  • cell membranes (activation sphingomyelinase and leading to hydrolysis of sphingomyelin to ceramide)
  • mitochondrial damage (ceramide-mediated process, mitochondrial ceramide synthase activation)